3 Best ETFs to Invest In, According to AI Analyst, 12/15/2025
TipRanks (Mon, 15-Dec 9:22 AM ET)
McKesson Corporation Declares Quarterly Dividend
Business Wire (Thu, 30-Oct 8:00 AM ET)
Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR Commercial Launch
PRNewswire (Mon, 20-Oct 8:37 AM ET)
Business Wire (Tue, 23-Sep 8:00 AM ET)
McKesson Announces New Organizational Structure
Business Wire (Thu, 18-Sep 8:00 AM ET)
Bullish On MCK? You Might Want To Consider This Credit Put Spread Expiring in 6 Days
Market Chameleon (Fri, 2-Aug 9:12 AM ET)
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Mckesson trades on the NYSE stock market under the symbol MCK.
As of December 16, 2025, MCK stock price declined to $809.96 with 566,522 million shares trading.
MCK has a beta of -0.07, meaning it tends to be less sensitive to market movements. MCK has a correlation of 0.00 to the broad based SPY ETF.
MCK has a market cap of $99.97 billion. This is considered a Large Cap stock.
Last quarter Mckesson reported $103 billion in Revenue and $9.86 earnings per share. This fell short of revenue expectation by $-1 billion and exceeded earnings estimates by $.86.
In the last 3 years, MCK traded as high as $895.58 and as low as $331.75.
The top ETF exchange traded funds that MCK belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.
MCK has outperformed the market in the last year with a return of +41.1%, while the SPY ETF gained +13.6%. In the last 3 month period, MCK beat the market returning +15.4%, while SPY returned +3.0%. However, in the most recent 2 weeks MCK has underperformed the stock market by returning -5.5%, while SPY returned -0.2%.
MCK support price is $810.35 and resistance is $835.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MCK shares will trade within this expected range on the day.
